The latest closing stock price for Esperion Therapeutics as of November 08, 2024 is 2.28.
An investor who bought $1,000 worth of Esperion Therapeutics stock at the IPO in 2013 would have $-843 today, roughly -1 times their original investment - a -15.48% compound annual growth rate over 11 years.
The all-time high Esperion Therapeutics stock closing price was 115.30 on May 19, 2015.
The Esperion Therapeutics 52-week high stock price is 3.40, which is 49.1% above the current share price.
The Esperion Therapeutics 52-week low stock price is 0.87, which is 61.8% below the current share price.
The average Esperion Therapeutics stock price for the last 52 weeks is 2.16.
An investor who bought $1,000 worth of Esperion Therapeutics stock at the IPO in 2013 would have $-843 today, roughly -1 times their original investment - a -15.48% compound annual growth rate over 11 years.
The all-time high Esperion Therapeutics stock closing price was 115.30 on May 19, 2015.
The Esperion Therapeutics 52-week high stock price is 3.40, which is 49.1% above the current share price.
The Esperion Therapeutics 52-week low stock price is 0.87, which is 61.8% below the current share price.
The average Esperion Therapeutics stock price for the last 52 weeks is 2.16.